ALCOBRA PHARMACEUTICALS

Alcobra Pharmaceuticals Inc., which is developing a treatment for attention deficit hyperactivity disorder (ADHD) held its Nasdaq IPO last night (Israel time). Sources said that the company had obtained positive feedback during its road show. Just before the road show, the company expanded its prospectus from issuing 1.36 million share to 2.27 million shares. Alcobra held the offering at $8 per share, raising a gross $25 million at a company value of $89 million. The company had hoped to raise the money at a share proce of between $10 and $12. It will be traded under the ticker "ADHD".

#SimilarOrganizations #People #Financial #Website #More

ALCOBRA PHARMACEUTICALS

Social Links:

Industry:

Biotechnology

Founded:

2008-01-01

Address:

Tel Aviv, Tel Aviv, Israel

Country:

Israel

Website Url:

http://www.alcobra-pharma.com

Total Employee:

11+

Status:

Active

Contact:

+972 72-220-4661

Email Addresses:

[email protected]

Total Funding:

28.5 M ILS

Technology used in webpage:

Japanese Server Location

Similar Organizations

akcea-therapeutics-logo

Current Advisors List

daniel-geffken_image

Daniel Geffken Board of Directors; Audit Committee, Compensation Committee @ Alcobra Pharmaceuticals
Board_member
2013-01-01

Founder

dalia-megiddo_image

Dalia Megiddo

udi-gilboa_image

Udi Gilboa

Stock Details

Company's stock symbol is NASDAQ:ADHD

Investors List

cybele-holdings_image

Cybele Holdings

Cybele Holdings investment in Post-IPO Equity - Alcobra Pharmaceuticals

Official Site Inspections

http://www.alcobra-pharma.com

Host Informations
Whois Informations

Loading ...